Abraxane developer Iglesias joins Senti Biosciences; AB2Bio recruits CEO
| Endpoints

After accumulating more than 30 years of biopharma experience, Jose Iglesias has been named CMO of Senti Biosciences, a gene circuit company based in the San Francisco area. Iglesias is slated to lead Senti’s clinical development programs with an emphasis on treating solid and liquid tumors. Iglesias designed the cancer drug Abraxane while he was […]

Trovagene Exploring PLK1 Inhibitor in Various Biomarker-Defined Cancer Indications
| Precision Oncology News

Trovagene is exploring the activity of its PLK1 inhibitor onvansertib in three biomarker-defined cancer indications and, based on […]

FDA Cites Shortage of One Drug, Exposing Supply-Line Worry
| The Wall Street Journal

Factory shutdowns across China because of the new coronavirus have exposed an uncomfortable health-care reality: Many medicines rely on raw materials that are made in that country. The U.S. Food and Drug Administration late Thursday said one drug […]